Keros Therapeutics (KROS) Liabilities and Shareholders Equity (2019 - 2026)
Keros Therapeutics (KROS) reported Liabilities and Shareholders Equity of $287.6 million for Q2 2026, down 62.0% from $757.17 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics posted Liabilities and Shareholders Equity of $338.02 million, down 45.1% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $615.89 million in FY2024 (+66.4%), $370.03 million in FY2023 (+20.6%), $306.78 million in FY2022 (+20.2%) and $255.25 million in FY2021 (-5.3%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q3 2022.
- Year over year, Liabilities and Shareholders Equity gained in five of the last seven quarters, with growth averaging 27.6%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2024 (growth of 77.6%); the low point was Q2 2026 (a decline of 62.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Keros Therapeutics | 221.17 Mn | -1.71 Bn | - | 287.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 287.60 Mn |
| Dec 31, 2025 | 338.02 Mn |
| Sep 30, 2025 | 742.78 Mn |
| Jun 30, 2025 | 757.17 Mn |
| Mar 31, 2025 | 784.56 Mn |
| Dec 31, 2024 | 615.89 Mn |
| Sep 30, 2024 | 579.27 Mn |
| Jun 30, 2024 | 455.02 Mn |
| Mar 31, 2024 | 485.82 Mn |
| Dec 31, 2023 | 370.03 Mn |
| Sep 30, 2023 | 326.25 Mn |
| Jun 30, 2023 | 356.31 Mn |
| Mar 31, 2023 | 384.44 Mn |
| Dec 31, 2022 | 306.78 Mn |
| Sep 30, 2022 | 252.55 Mn |
| Jun 30, 2022 | 226.66 Mn |
| Mar 31, 2022 | 235.14 Mn |
| Dec 31, 2021 | 255.25 Mn |
| Sep 30, 2021 | 229.96 Mn |
| Jun 30, 2021 | 243.46 Mn |
API Access
Keros Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();